Skip to content
10-Q

Quarterly Report

GUIDED THERAPEUTICS INC GTHP

0001477932-24-007162

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 11, 2024 61.02M sh
Stock Issued Q3 2024 · Sep 30, 2024 6.35M sh
Current Liabilities Q3 2024 · Sep 30, 2024 $6.03M
Current Liabilities Q3 2024 · Dec 31, 2023 $4.81M
Total Liabilities Q3 2024 · Sep 30, 2024 $6.17M
Total Liabilities Q3 2024 · Dec 31, 2023 $5.48M
Current Assets Q3 2024 · Sep 30, 2024 $1.04M
Current Assets Q3 2024 · Dec 31, 2023 $1.39M
Total Assets Q3 2024 · Sep 30, 2024 $1.25M
Total Assets Q3 2024 · Dec 31, 2023 $1.67M
Shares Diluted Q3 2024 · Sep 30, 2023 51.47M sh
Shares Diluted Q3 2024 · Sep 30, 2023 50.59M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$1.41M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$3.65M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$3.32M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$2.88M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.07
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 −$0.07
Sga Expense Q3 2024 · Sep 30, 2023 $481K
Sga Expense Q3 2024 · Sep 30, 2023 $2.65M
Rd Expense Q3 2024 · Sep 30, 2023 $69K
Rd Expense Q3 2024 · Sep 30, 2023 $142K
Net Income Q3 2024 · Sep 30, 2023 −$677K
Net Income Q3 2024 · Sep 30, 2023 −$3.1M
Operating Income Q3 2024 · Sep 30, 2023 −$623K
Operating Income Q3 2024 · Sep 30, 2023 −$2.97M
Gross Profit Q3 2024 · Sep 30, 2023 −$4K
Gross Profit Q3 2024 · Sep 30, 2023 $20K
Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2023 $66K